ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Companion Diagnostic Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-9Z15758
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Cancer Companion Diagnostic Market Research Report 2023
BUY CHAPTERS

Global Cancer Companion Diagnostic Market Research Report 2025

Code: QYRE-Auto-9Z15758
Report
May 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amoydx
Novogene
Illumina Inc
Roche
Agilent
Abbott
Thermo Fisher
Qiagen NV
Guardant Health

Cancer Companion Diagnostic Market

The global market for Cancer Companion Diagnostic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Companion diagnostic (CD) is an in vitro diagnostic technology that can provide information about a patient"s therapeutic response to a specific therapeutic drug, helping to identify patient groups who can benefit from a certain therapeutic product, thereby improving treatment prognosis. and reduce health care costs. Additionally, companion diagnostics can help identify patient populations most likely to respond to therapeutic agents. The companion diagnostics market is still in its early stages.
The number of cancer patients is gradually increasing, drug accessibility is improving, and the research and development of targeted drugs and immunotherapy continue to increase. This is the main trend of drug development in the next ten years.
This report aims to provide a comprehensive presentation of the global market for Cancer Companion Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Companion Diagnostic.
The Cancer Companion Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Companion Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Companion Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cancer Companion Diagnostic Market Report

Report Metric Details
Report Name Cancer Companion Diagnostic Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AmoyDx, Novogene, Illumina, Roche, Agilent, Abbott, Thermo Fisher, Qiagen, Guardant Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Companion Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Companion Diagnostic Market report?

Ans: The main players in the Cancer Companion Diagnostic Market are AmoyDx, Novogene, Illumina, Roche, Agilent, Abbott, Thermo Fisher, Qiagen, Guardant Health

What are the Application segmentation covered in the Cancer Companion Diagnostic Market report?

Ans: The Applications covered in the Cancer Companion Diagnostic Market report are Lung Cancer, Colorectal Cancer, Breast Cancer, Others

What are the Type segmentation covered in the Cancer Companion Diagnostic Market report?

Ans: The Types covered in the Cancer Companion Diagnostic Market report are Polymerase Chain Reaction (PCR), “Next Generation” Sequencing (NGS), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC)

Recommended Reports

Cancer Diagnostics

Companion & Precision

Specific Cancer Types

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Companion Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 “Next Generation” Sequencing (NGS)
1.2.4 Fluorescence In Situ Hybridization (FISH)
1.2.5 Immunohistochemistry (IHC)
1.3 Market by Application
1.3.1 Global Cancer Companion Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer
1.3.3 Colorectal Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Companion Diagnostic Market Perspective (2020-2031)
2.2 Global Cancer Companion Diagnostic Growth Trends by Region
2.2.1 Global Cancer Companion Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Companion Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Cancer Companion Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Cancer Companion Diagnostic Market Dynamics
2.3.1 Cancer Companion Diagnostic Industry Trends
2.3.2 Cancer Companion Diagnostic Market Drivers
2.3.3 Cancer Companion Diagnostic Market Challenges
2.3.4 Cancer Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Companion Diagnostic Players by Revenue
3.1.1 Global Top Cancer Companion Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Cancer Companion Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Companion Diagnostic Revenue
3.4 Global Cancer Companion Diagnostic Market Concentration Ratio
3.4.1 Global Cancer Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Companion Diagnostic Revenue in 2024
3.5 Global Key Players of Cancer Companion Diagnostic Head office and Area Served
3.6 Global Key Players of Cancer Companion Diagnostic, Product and Application
3.7 Global Key Players of Cancer Companion Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Companion Diagnostic Breakdown Data by Type
4.1 Global Cancer Companion Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Cancer Companion Diagnostic Forecasted Market Size by Type (2026-2031)
5 Cancer Companion Diagnostic Breakdown Data by Application
5.1 Global Cancer Companion Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Cancer Companion Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Companion Diagnostic Market Size (2020-2031)
6.2 North America Cancer Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Companion Diagnostic Market Size by Country (2020-2025)
6.4 North America Cancer Companion Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Companion Diagnostic Market Size (2020-2031)
7.2 Europe Cancer Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Companion Diagnostic Market Size by Country (2020-2025)
7.4 Europe Cancer Companion Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Companion Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Cancer Companion Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Companion Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Companion Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Companion Diagnostic Market Size (2020-2031)
9.2 Latin America Cancer Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Companion Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Cancer Companion Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Companion Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Cancer Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Companion Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Companion Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AmoyDx
11.1.1 AmoyDx Company Details
11.1.2 AmoyDx Business Overview
11.1.3 AmoyDx Cancer Companion Diagnostic Introduction
11.1.4 AmoyDx Revenue in Cancer Companion Diagnostic Business (2020-2025)
11.1.5 AmoyDx Recent Development
11.2 Novogene
11.2.1 Novogene Company Details
11.2.2 Novogene Business Overview
11.2.3 Novogene Cancer Companion Diagnostic Introduction
11.2.4 Novogene Revenue in Cancer Companion Diagnostic Business (2020-2025)
11.2.5 Novogene Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Cancer Companion Diagnostic Introduction
11.3.4 Illumina Revenue in Cancer Companion Diagnostic Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Cancer Companion Diagnostic Introduction
11.4.4 Roche Revenue in Cancer Companion Diagnostic Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Agilent
11.5.1 Agilent Company Details
11.5.2 Agilent Business Overview
11.5.3 Agilent Cancer Companion Diagnostic Introduction
11.5.4 Agilent Revenue in Cancer Companion Diagnostic Business (2020-2025)
11.5.5 Agilent Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Cancer Companion Diagnostic Introduction
11.6.4 Abbott Revenue in Cancer Companion Diagnostic Business (2020-2025)
11.6.5 Abbott Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Cancer Companion Diagnostic Introduction
11.7.4 Thermo Fisher Revenue in Cancer Companion Diagnostic Business (2020-2025)
11.7.5 Thermo Fisher Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Cancer Companion Diagnostic Introduction
11.8.4 Qiagen Revenue in Cancer Companion Diagnostic Business (2020-2025)
11.8.5 Qiagen Recent Development
11.9 Guardant Health
11.9.1 Guardant Health Company Details
11.9.2 Guardant Health Business Overview
11.9.3 Guardant Health Cancer Companion Diagnostic Introduction
11.9.4 Guardant Health Revenue in Cancer Companion Diagnostic Business (2020-2025)
11.9.5 Guardant Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Amoydx
Novogene
Illumina Inc
Roche
Agilent
Abbott
Thermo Fisher
Qiagen NV
Guardant Health
List of Tables
 Table 1. Global Cancer Companion Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Polymerase Chain Reaction (PCR)
 Table 3. Key Players of “Next Generation” Sequencing (NGS)
 Table 4. Key Players of Fluorescence In Situ Hybridization (FISH)
 Table 5. Key Players of Immunohistochemistry (IHC)
 Table 6. Global Cancer Companion Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cancer Companion Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Cancer Companion Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Cancer Companion Diagnostic Market Share by Region (2020-2025)
 Table 10. Global Cancer Companion Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Cancer Companion Diagnostic Market Share by Region (2026-2031)
 Table 12. Cancer Companion Diagnostic Market Trends
 Table 13. Cancer Companion Diagnostic Market Drivers
 Table 14. Cancer Companion Diagnostic Market Challenges
 Table 15. Cancer Companion Diagnostic Market Restraints
 Table 16. Global Cancer Companion Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Cancer Companion Diagnostic Market Share by Players (2020-2025)
 Table 18. Global Top Cancer Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Companion Diagnostic as of 2024)
 Table 19. Ranking of Global Top Cancer Companion Diagnostic Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Cancer Companion Diagnostic Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Cancer Companion Diagnostic, Headquarters and Area Served
 Table 22. Global Key Players of Cancer Companion Diagnostic, Product and Application
 Table 23. Global Key Players of Cancer Companion Diagnostic, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Cancer Companion Diagnostic Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Cancer Companion Diagnostic Revenue Market Share by Type (2020-2025)
 Table 27. Global Cancer Companion Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Cancer Companion Diagnostic Revenue Market Share by Type (2026-2031)
 Table 29. Global Cancer Companion Diagnostic Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Cancer Companion Diagnostic Revenue Market Share by Application (2020-2025)
 Table 31. Global Cancer Companion Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Cancer Companion Diagnostic Revenue Market Share by Application (2026-2031)
 Table 33. North America Cancer Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Cancer Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Cancer Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Cancer Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Cancer Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Cancer Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Cancer Companion Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Cancer Companion Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Cancer Companion Diagnostic Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Cancer Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Cancer Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cancer Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Cancer Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Cancer Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Cancer Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. AmoyDx Company Details
 Table 49. AmoyDx Business Overview
 Table 50. AmoyDx Cancer Companion Diagnostic Product
 Table 51. AmoyDx Revenue in Cancer Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 52. AmoyDx Recent Development
 Table 53. Novogene Company Details
 Table 54. Novogene Business Overview
 Table 55. Novogene Cancer Companion Diagnostic Product
 Table 56. Novogene Revenue in Cancer Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 57. Novogene Recent Development
 Table 58. Illumina Company Details
 Table 59. Illumina Business Overview
 Table 60. Illumina Cancer Companion Diagnostic Product
 Table 61. Illumina Revenue in Cancer Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 62. Illumina Recent Development
 Table 63. Roche Company Details
 Table 64. Roche Business Overview
 Table 65. Roche Cancer Companion Diagnostic Product
 Table 66. Roche Revenue in Cancer Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 67. Roche Recent Development
 Table 68. Agilent Company Details
 Table 69. Agilent Business Overview
 Table 70. Agilent Cancer Companion Diagnostic Product
 Table 71. Agilent Revenue in Cancer Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 72. Agilent Recent Development
 Table 73. Abbott Company Details
 Table 74. Abbott Business Overview
 Table 75. Abbott Cancer Companion Diagnostic Product
 Table 76. Abbott Revenue in Cancer Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 77. Abbott Recent Development
 Table 78. Thermo Fisher Company Details
 Table 79. Thermo Fisher Business Overview
 Table 80. Thermo Fisher Cancer Companion Diagnostic Product
 Table 81. Thermo Fisher Revenue in Cancer Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 82. Thermo Fisher Recent Development
 Table 83. Qiagen Company Details
 Table 84. Qiagen Business Overview
 Table 85. Qiagen Cancer Companion Diagnostic Product
 Table 86. Qiagen Revenue in Cancer Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 87. Qiagen Recent Development
 Table 88. Guardant Health Company Details
 Table 89. Guardant Health Business Overview
 Table 90. Guardant Health Cancer Companion Diagnostic Product
 Table 91. Guardant Health Revenue in Cancer Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 92. Guardant Health Recent Development
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Cancer Companion Diagnostic Picture
 Figure 2. Global Cancer Companion Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Companion Diagnostic Market Share by Type: 2024 VS 2031
 Figure 4. Polymerase Chain Reaction (PCR) Features
 Figure 5. “Next Generation” Sequencing (NGS) Features
 Figure 6. Fluorescence In Situ Hybridization (FISH) Features
 Figure 7. Immunohistochemistry (IHC) Features
 Figure 8. Global Cancer Companion Diagnostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Cancer Companion Diagnostic Market Share by Application: 2024 VS 2031
 Figure 10. Lung Cancer Case Studies
 Figure 11. Colorectal Cancer Case Studies
 Figure 12. Breast Cancer Case Studies
 Figure 13. Others Case Studies
 Figure 14. Cancer Companion Diagnostic Report Years Considered
 Figure 15. Global Cancer Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Cancer Companion Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Cancer Companion Diagnostic Market Share by Region: 2024 VS 2031
 Figure 18. Global Cancer Companion Diagnostic Market Share by Players in 2024
 Figure 19. Global Top Cancer Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Companion Diagnostic as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Cancer Companion Diagnostic Revenue in 2024
 Figure 21. North America Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Cancer Companion Diagnostic Market Share by Country (2020-2031)
 Figure 23. United States Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Cancer Companion Diagnostic Market Share by Country (2020-2031)
 Figure 27. Germany Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Cancer Companion Diagnostic Market Share by Region (2020-2031)
 Figure 35. China Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Cancer Companion Diagnostic Market Share by Country (2020-2031)
 Figure 43. Mexico Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Cancer Companion Diagnostic Market Share by Country (2020-2031)
 Figure 47. Turkey Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Cancer Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. AmoyDx Revenue Growth Rate in Cancer Companion Diagnostic Business (2020-2025)
 Figure 51. Novogene Revenue Growth Rate in Cancer Companion Diagnostic Business (2020-2025)
 Figure 52. Illumina Revenue Growth Rate in Cancer Companion Diagnostic Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in Cancer Companion Diagnostic Business (2020-2025)
 Figure 54. Agilent Revenue Growth Rate in Cancer Companion Diagnostic Business (2020-2025)
 Figure 55. Abbott Revenue Growth Rate in Cancer Companion Diagnostic Business (2020-2025)
 Figure 56. Thermo Fisher Revenue Growth Rate in Cancer Companion Diagnostic Business (2020-2025)
 Figure 57. Qiagen Revenue Growth Rate in Cancer Companion Diagnostic Business (2020-2025)
 Figure 58. Guardant Health Revenue Growth Rate in Cancer Companion Diagnostic Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Companion Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digital Companion Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Companion Diagnostic Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Companion Diagnostics for Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Companion Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Companion Diagnostic Market Research Report 2024
Global Companion Diagnostics Devices Market Research Report 2025
Global Companion Diagnostics CDx Development Services Market Research Report 2024
Companion Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Companion Animal Diagnostics Market Research Report 2024
Companion Animal Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Precision Cancer Diagnostic Tests Market
Global In Vitro Diagnostic IVD Products Market Research Report 2024
Global In Vitro Diagnostics IVDs Medical Device Market Research Report 2025
Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2030
Global Diagnostics and Imaging Assistance Market Research Report 2024
In Vitro Diagnostic IVD Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IVD In Vitro Diagnostics Products Market Research Report 2024
In Vitro Diagnostic Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Diagnostic IVD Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions